Cargando…
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
α1-antitrypsin (AAT) is a circulating serine protease inhibitor secreted from the liver and important in preventing proteolytic neutrophil elastase associated tissue damage, primarily in lungs. In humans, AAT is encoded by the SERPINA1 (hSERPINA1) gene in which a point mutation (commonly referred to...
Autores principales: | Bjursell, Mikael, Porritt, Michelle J., Ericson, Elke, Taheri-Ghahfarokhi, Amir, Clausen, Maryam, Magnusson, Lisa, Admyre, Therese, Nitsch, Roberto, Mayr, Lorenz, Aasehaug, Leif, Seeliger, Frank, Maresca, Marcello, Bohlooly-Y, Mohammad, Wiseman, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925576/ https://www.ncbi.nlm.nih.gov/pubmed/29500128 http://dx.doi.org/10.1016/j.ebiom.2018.02.015 |
Ejemplares similares
-
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
por: Carreras, Alba, et al.
Publicado: (2019) -
In vivo CRISPR editing with no detectable genome-wide off-target mutations
por: Akcakaya, Pinar, et al.
Publicado: (2018) -
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
por: Lundin, Anders, et al.
Publicado: (2020) -
Decoding non-random mutational signatures at Cas9 targeted sites
por: Taheri-Ghahfarokhi, Amir, et al.
Publicado: (2018) -
Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH
por: Bjursell, Mikael, et al.
Publicado: (2013)